NXPL Stock Overview
Operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
NextPlat Corp Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.19 |
| 52 Week High | US$3.08 |
| 52 Week Low | US$1.00 |
| Beta | 0.93 |
| 11 Month Change | 7.06% |
| 3 Month Change | -0.68% |
| 1 Year Change | -55.82% |
| 33 Year Change | -82.37% |
| 5 Year Change | -95.20% |
| Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| NXPL | US Telecom | US Market | |
|---|---|---|---|
| 7D | -1.0% | -2.1% | -2.4% |
| 1Y | -55.8% | 23.5% | 17.5% |
Return vs Industry: NXPL underperformed the US Telecom industry which returned 19.9% over the past year.
Return vs Market: NXPL underperformed the US Market which returned 17.2% over the past year.
Price Volatility
| NXPL volatility | |
|---|---|
| NXPL Average Weekly Movement | 7.7% |
| Telecom Industry Average Movement | 5.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NXPL's share price has been volatile over the past 3 months.
Volatility Over Time: NXPL's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 154 | Charles Fernandez | www.nextplat.com |
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities. It also offers COVID-19 related diagnostics and vaccinations, and medication adherence packaging; and value-added services, such as prior authorization assistance, same-day home-medication delivery, on site provider consultation services, primary care reporting and analytics, and customized packaging solutions, as well as acquires and leases an e-commerce platform to collaborate with businesses to optimize their ability to sell their goods online.
NextPlat Corp Fundamentals Summary
| NXPL fundamental statistics | |
|---|---|
| Market cap | US$22.25m |
| Earnings (TTM) | -US$4.07m |
| Revenue (TTM) | US$52.37m |
0.4x
P/S Ratio-5.5x
P/E RatioIs NXPL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NXPL income statement (TTM) | |
|---|---|
| Revenue | US$52.37m |
| Cost of Revenue | US$37.01m |
| Gross Profit | US$15.37m |
| Other Expenses | US$19.44m |
| Earnings | -US$4.07m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.22 |
| Gross Margin | 29.34% |
| Net Profit Margin | -7.78% |
| Debt/Equity Ratio | 3.1% |
How did NXPL perform over the long term?
See historical performance and comparison